Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 279,459 $ 226,204
Equity method investments 1,935,467 1,759,651
Receivables 1,557,000  
Receivables held-for-sale 74,109 22,214
Real estate 359,106 356,088
Investments 11,643 17,697
Securitization assets 178,156 210,354
Other assets 124,748 132,165
Total Assets 4,519,018 4,148,311
Liabilities:    
Accounts payable, accrued expenses and other 105,200 88,866
Credit facilities 201,032 100,473
Commercial paper notes 100,174 50,094
Senior unsecured notes 1,765,195 1,762,763
Convertible notes 339,559 149,731
Total Liabilities 2,927,503 2,581,796
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 87,489,951 and 85,326,781 shares issued and outstanding, respectively 875 853
Additional paid in capital 1,811,889 1,727,667
Accumulated deficit (232,590) (193,706)
Accumulated other comprehensive income (loss) (22,132) 9,904
Non-controlling interest 33,473 21,797
Total Stockholders’ Equity 1,591,515 1,566,515
Total Liabilities and Stockholders’ Equity 4,519,018 4,148,311
Commercial receivables    
Assets    
Receivables 1,445,576 1,298,529
Government receivables    
Assets    
Receivables 110,754 125,409
Nonrecourse    
Liabilities:    
Non-recourse debt (secured by assets of $553 million and $573 million, respectively) $ 416,343 $ 429,869